This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
Opioid and methamphetamine data system: DOA to establish, collect data from other departments, and submit report to JCF [S.Amdt.2: appropriation removed] - SB49
Opioid and methamphetamine data system established; data collected from certain departments, report to JCF required - AB444
Opioid and methamphetamine data system established; data collected from certain departments, report to JCF required - SB439
Patient pharmacy benefit tool re cost of prescription drugs: grants to develop and implement [Sec. 2910] [original bill only] - AB68
Patient pharmacy benefit tool re cost of prescription drugs: grants to develop and implement [Sec. 2910] - SB111
Patient pharmacy benefit tool re cost of prescription drugs: grants to develop and implement; special education, UW System, and TCS funding provision - AB549
Patient pharmacy benefit tool re cost of prescription drugs: grants to develop and implement - SB554
Pharmacist training on dispensing opioid antagonists required [Sec. 2879, 2882, 9138 (2)] [original bill only] - AB68
Pharmacist training on dispensing opioid antagonists required [Sec. 2879, 2882, 9138 (2)] - SB111
Pharmacists authorized to extend a prescription order: 2019 WisAct 185 provisions extended - AB1
Pharmacists authorized to extend a prescription order: 2020 public health emergency provision extended - SB149
Pharmacists authorized to extend a prescription order, expires December 31, 2021 - AB31
Pharmacy benefit manager license and regulation requirements; pharmacy requirements re drug substitution, listing of retail prices and generic and corresponding brand name drugs, and notification of changes to prescription benefits [Sec. 730, 733, 734, 1117, 2163, 2397, 2885-2887, 2906, 2911, 2924, 2926, 2954, 2955, 2959-2963, 2965, 2987-3009, 9123 (1), 9323 (1), 9423 (1)] [original bill only] - AB68
Pharmacy benefit manager license and regulation requirements; pharmacy requirements re drug substitution, listing of retail prices and generic and corresponding brand name drugs, and notification of changes to prescription benefits [Sec. 730, 733, 734, 1117, 2163, 2397, 2885-2887, 2906, 2911, 2924, 2926, 2954, 2955, 2959-2963, 2965, 2987-3009, 9123 (1), 9323 (1), 9423 (1)] - SB111
Pharmacy benefit manager licensure requirements and regulations; cost-sharing limitation; specified disclosures to customers; notification of drug substitution - AB7
Pharmacy benefit manager licensure requirements and regulations; cost-sharing limitation; specified disclosures to customers; notification of drug substitution - SB3
Pharmacy technicians authorized to administer vaccines; any health care provider authorized to administer vaccines may supervise pharmacy students administering vaccines [A.Amdt.1: adds administration of specified drugs for adverse reactions; S.Amdt.1: adds use of the title “pharmacist” provision] - AB4
Prescription Drug Affordability, Office of, in the OCI: funding for establishment of and FTE positions - AB556
Prescription Drug Affordability, Office of, in the OCI: funding for establishment of and FTE positions - SB578
Prescription Drug Affordability Review Board created - AB544
Prescription Drug Affordability Review Board created [Sec. 67, 88, 2914-2917, 9123 (8), 9423 (4)] [original bill only] - AB68
Prescription Drug Affordability Review Board created [Sec. 67, 88, 2914-2917, 9123 (8), 9423 (4)] - SB111
Prescription Drug Affordability Review Board created - SB540
Prescription drug cost reporting by manufacturers: requirements established - AB512
Prescription drug cost reporting by manufacturers: requirements established - SB499
Prescription drug cost reporting requirements [Sec. 2953, 2967, 9123 (3)] [original bill only] - AB68
Prescription drug cost reporting requirements [Sec. 2953, 2967, 9123 (3)] - SB111
Prescription drug importation program established [Sec. 2912, 9123 (2)] [original bill only] - AB68
Prescription drug importation program established; JCF approval required - AB548
Prescription drug importation program established [Sec. 2912, 9123 (2)] - SB111
Prescription drug importation program established; JCF approval required - SB539
Prescription drug limits prohibition enacted in 2019 WisAct 185 reinstated - AB1
Prescription drug limits prohibition enacted in 2019 WisAct 185 reinstated, period specified - AB31
Prescription drug limits prohibition enacted in 2019 WisAct 185 reinstated, period specified - SB130
Prescription Drug Monitoring Program: certain exemption to review of patient’s records repealed - AB430
Prescription Drug Monitoring Program: certain exemption to review of patient’s records repealed - SB407
Prescription drug payments made by enrollee applied to health insurance out-of-pocket maximum or cost-sharing requirements - AB184
Prescription drug payments made by enrollee applied to health insurance out-of-pocket maximum or cost-sharing requirements - SB215
Reckless handling of a vaccine or drug rendering it ineffective or unusable made a felony; JRCCP may report - AB225
Reckless handling of a vaccine or drug rendering it ineffective or unusable made a felony; JRCCP may report [S.Amdt.1: "reckless handling" changed to "intentional destruction"] - SB242
State prescription drug purchasing entity study - AB558
State prescription drug purchasing entity study [Sec. 9123 (6)] - SB111
State prescription drug purchasing entity study [Sec. 9123 (6)] [original bill only] - AB68
State prescription drug purchasing entity study - SB551
Step therapy protocol for certain cancer drugs: insurer, pharmacy benefit manager, or utilization review organization prohibited from requiring - AB745
Step therapy protocol for certain cancer drugs: insurer, pharmacy benefit manager, or utilization review organization prohibited from requiring - SB716
Tax revisions re obsolete statutory references, electronic assessment rolls, Internet equipment in the broadband market, property tax assessment objections, and sales tax exemptions for insulin, farm-raised fish, and patient health care records (remedial legislation suggested by DOR) - AB1033
Tax revisions re obsolete statutory references, electronic assessment rolls, Internet equipment in the broadband market, property tax assessment objections, and sales tax exemptions for insulin, farm-raised fish, and patient health care records (remedial legislation suggested by DOR) - SB1020
Third-party logistics providers: optional license created; Pharmacy Examining Board duties - AB1
Third-party logistics providers: optional license created; Pharmacy Examining Board duties - SB144
Third-party logistics providers: optional license created; Pharmacy Examining Board duties [A.Amdt.1: applicability provision modified] - AB120
Third-party logistics providers: optional license created; Pharmacy Examining Board duties - SB163
Third-party logistics providers: optional license created; Pharmacy Examining Board duties and interim license - AB31
Unfair drug pricing practices and fraudulent drug advertising prohibitions [Sec. 1567, 1570] [original bill only] - AB68
Unfair drug pricing practices and fraudulent drug advertising prohibitions [Sec. 1567, 1570] - SB111
Unfair Sales Act exemption for items that are qualified medical expenses - AB358
Unfair Sales Act exemption for items that are qualified medical expenses - SB357
Value-based diabetes medication pilot program [Sec. 2908] [original bill only] - AB68
Value-based diabetes medication pilot program [Sec. 2908] - SB111
Value-based diabetes medication pilot project established - AB551
Value-based diabetes medication pilot project established - SB550
Wisconsin drug repository program revisions, study required - AB546
Wisconsin drug repository program revisions, study required [Sec. 2595, 9119 (4)] [original bill only] - AB68
Wisconsin drug repository program revisions, study required [Sec. 2595, 9119 (4)] - SB111
Wisconsin drug repository program revisions, study required - SB577
drugs _ criminal acts and law enforcementDrugs — Criminal acts and law enforcement
Butane extraction used to manufacture marijuana or separate plant resin from marijuana plants: penalty revisions; JRCCP may report - AB440
Butane extraction used to manufacture marijuana or separate plant resin from marijuana plants: penalty revisions; JRCCP may report - SB440
Drug paraphernalia definition excludes materials used to test for fentanyl [Sec. 3398] [original bill only] - AB68
Drug paraphernalia definition excludes materials used to test for fentanyl [Sec. 3398] - SB111
Fentanyl and fentanyl analogs: felony penalties for manufacture, distribution, delivery, or possession revised; JRCCP may report - AB357
Fentanyl and fentanyl analogs: felony penalties for manufacture, distribution, delivery, or possession revised; JRCCP may report - SB352
Fentanyl testing strips excluded from definition of drug paraphernalia - AB619
Fentanyl testing strips excluded from definition of drug paraphernalia - SB600
Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent [Sec. 3382-3384] [original bill only] - AB68
Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent [Sec. 3382-3384] - SB111
Immunity from prosecution for person aiding a person experiencing a drug overdose: providing assistance as soon as reasonably possible condition added - AB921
Immunity from prosecution for person aiding a person experiencing a drug overdose: providing assistance as soon as reasonably possible condition added - SB878
Indoor smoking ban applied to electronic smoking devices and marijuana; “smoking” definition revised - AB1123
Indoor smoking ban applied to electronic smoking devices and marijuana; “smoking” definition revised - SB1031
Legalizing recreational marijuana; JRCCP may report; JSCTE appendix report - AB846
Legalizing recreational marijuana; JRCCP may report; JSCTE appendix report - SB545
Marijuana possession of not more than 10 grams: penalty reduced to a forfeiture, local government ordinance preemption; deposit in lieu of court appearance provision; JRCCP may report - AB130
Marijuana possession of not more than 10 grams: penalty reduced to a forfeiture, local government ordinance preemption; deposit in lieu of court appearance provision; JRCCP may report - SB164
Marijuana possession penalties revised, ordinance and law enforcement provisions; limited liability for employer that does not require drug testing as condition of employment; JRCCP may report - AB812
Marijuana possession penalties revised, ordinance and law enforcement provisions; limited liability for employer that does not require drug testing as condition of employment; JRCCP may report - SB790
Marijuana: recreational use legalized, permit required; portion of excise tax revenue deposited in community reinvestment fund to promote diversity and equity; medical marijuana registry created; JLC study [Sec. 265, 266, 292, 317, 411, 467, 498, 502, 610, 888, 959, 1053, 1085, 1086, 1112, 1136, 1404, 1433, 1563-1566, 1732, 1743, 1796, 1797, 1811, 1893, 1894, 1909, 2269, 2291, 2292, 2649, 2829, 3367-3381, 3389, 3391-3397, 3404, 3405, 3417-3420, 3441, 9128 (2)] [original bill only] - AB68
Marijuana: recreational use legalized, permit required; portion of excise tax revenue deposited in community reinvestment fund to promote diversity and equity; medical marijuana registry created; JLC study [Sec. 265, 266, 292, 317, 411, 467, 498, 502, 610, 888, 959, 1053, 1085, 1086, 1112, 1136, 1404, 1433, 1563-1566, 1732, 1743, 1796, 1797, 1811, 1893, 1894, 1909, 2269, 2291, 2292, 2649, 2829, 3367-3381, 3389, 3391-3397, 3404, 3405, 3417-3420, 3441, 9128 (2)] - SB111
Medical cannabis: DHS to establish registry for specified medical conditions or treatments and issue ID cards; producer, processor, or dispensary to obtain license from DATCP, conditions and fee provisions; discrimination in employment and licensing prohibitions; medical use defense to THC-related prosecutions and forfeiture actions for registered persons; JRCCP may report - AB1063
Loading...
Loading...